Avacta Group Plc
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatec… Read more
Avacta Group Plc (AVCTF) - Total Assets
Latest total assets as of June 2025: $29.24 Million USD
Based on the latest financial reports, Avacta Group Plc (AVCTF) holds total assets worth $29.24 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Avacta Group Plc - Total Assets Trend (2000–2024)
This chart illustrates how Avacta Group Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Avacta Group Plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Avacta Group Plc's total assets of $29.24 Million consist of 83.3% current assets and 16.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $305.00K | 0.6% |
| Goodwill | $1.54 Million | 3.2% |
Asset Composition Trend (2000–2024)
This chart illustrates how Avacta Group Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Avacta Group Plc's current assets represent 83.3% of total assets in 2024, an increase from 11.3% in 2000.
- Cash Position: Cash and equivalents constituted 26.7% of total assets in 2024, up from 5.7% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 3.2% of total assets.
Avacta Group Plc Competitors by Total Assets
Key competitors of Avacta Group Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Avacta Group Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Avacta Group Plc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Avacta Group Plc is currently not profitable relative to its asset base.
Avacta Group Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.79 | 1.29 | 14.08 |
| Quick Ratio | 0.79 | 1.21 | 14.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-5.91 Million | $ 10.18 Million | $ 49.47 Million |
Avacta Group Plc - Advanced Valuation Insights
This section examines the relationship between Avacta Group Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1784.77 |
| Latest Market Cap to Assets Ratio | 3.67 |
| Asset Growth Rate (YoY) | -34.0% |
| Total Assets | $48.27 Million |
| Market Capitalization | $176.98 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Avacta Group Plc's assets at a significant premium ( 3.67x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Avacta Group Plc's assets decreased by 34.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Avacta Group Plc (2000–2024)
The table below shows the annual total assets of Avacta Group Plc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $48.27 Million | -34.05% |
| 2023-12-31 | $73.19 Million | -21.00% |
| 2022-12-31 | $92.65 Million | +97.12% |
| 2021-12-31 | $47.00 Million | -30.33% |
| 2020-12-31 | $67.46 Million | +137.46% |
| 2019-12-31 | $28.41 Million | 0.00% |
| 2019-07-31 | $28.41 Million | +21.14% |
| 2018-12-31 | $23.45 Million | -25.67% |
| 2017-12-31 | $31.55 Million | -15.98% |
| 2016-12-31 | $37.55 Million | +75.46% |
| 2015-12-31 | $21.40 Million | -31.07% |
| 2014-12-31 | $31.05 Million | +75.87% |
| 2013-12-31 | $17.66 Million | -4.51% |
| 2012-12-31 | $18.49 Million | +49.88% |
| 2011-12-31 | $12.34 Million | +9.92% |
| 2010-12-31 | $11.22 Million | +23.93% |
| 2009-12-31 | $9.05 Million | +76.03% |
| 2008-12-31 | $5.14 Million | +80.81% |
| 2007-12-31 | $2.85 Million | +8521.21% |
| 2005-12-31 | $33.00K | -84.65% |
| 2004-12-31 | $215.00K | -84.44% |
| 2003-12-31 | $1.38 Million | +659.34% |
| 2002-12-31 | $182.00K | +1.68% |
| 2001-12-31 | $179.00K | -15.57% |
| 2000-12-31 | $212.00K | -- |